|
1
|
Herbst RS, Heymach JV and Lippman SM: Lung
Cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Laoukili J, Kooistra MR, Brás A, et al:
FoxM1 is required for execution of the mitotic programme and
chromosome stability. Nat Cell Biol. 7:126–136. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Laoukili J, Stahl M and Medema RH: FoxM1:
at the crossroads of ageing and cancer. Biochim Biophys Acta.
1775:92–102. 2007.PubMed/NCBI
|
|
5
|
Wierstra I and Alves J: FOXM1, a typical
proliferation-associated transcription factor. Biol Chem.
388:1257–1274. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang DK, Son CH, Lee SK, Choi PJ, Lee KE
and Roh MS: Forkhead box M1 expression in pulmonary squamous cell
carcinoma: correlation with clinicopathologic features and its
prognostic significance. Hum Pathol. 40:464–470. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun HC, Li M, Lu JL, et al: Overexpression
of Forkhead box M1 protein associates with aggressive tumor
features and poor prognosis of hepatocellular carcinoma. Oncol Rep.
25:1533–1539. 2011.PubMed/NCBI
|
|
8
|
Bektas N, Haaf At, Veeck J, et al: Tight
correlation between expression of the Forkhead transcription factor
FOXM1 and HER2 in human breast cancer. BMC Cancer. 8:422008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu D, Zhang Z and Kong CZ: High FOXM1
expression was associated with bladder carcinogenesis. Tumour Biol.
34:1131–1138. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu XR, Chen YH, Liu DM, Sha JJ, Xuan HQ,
Bo JJ and Huang YR: Increased expression of forkhead box M1 protein
is associated with poor prognosis in clear cell renal cell
carcinoma. Med Oncol. 30:3462013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He SY, Shen HW, Xu L, et al: FOXM1
promotes tumor cell invasion and correlates with poor prognosis in
early-stage cervical cancer. Gynecol Oncol. 127:601–610. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu N, Jia D, Chen W, et al: FoxM1 is
associated with poor prognosis of non-small cell lung cancer
patients through promoting tumor metastasis. PLoS One.
8:e594122013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chu XY, Zhu ZM, Chen LB, et al: FOXM1
expression correlates with tumor invasion and a poor prognosis of
colorectal cancer. Acta Histochem. 114:755–762. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xue YJ, Xiao RH, Long DZ, et al:
Overexpression of FoxM1 is associated with tumor progression in
patients with clear cell renal cell carcinoma. J Transl Med.
10:2002012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Z, Banerjee S, Kong D, Li Y and
Sarkar FH: Down-regulation of Forkhead Box M1 transcription factor
leads to the inhibition of invasion and angiogenesis of pancreatic
cancer cells. Cancer Res. 67:8293–8300. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lynch TP, Ferrer CM, Jackson SR, Shahriari
KS, Vosseller K and Reginato MJ: Critical role of O-linked
β-N-acetylglucosamine transferase in prostate cancer
invasion, angiogenesis, and metastasis. J Biol Chem.
287:11070–11081. 2012.
|
|
17
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu YD and Zhou BP: Snail: more than EMT.
Cell Adh Migr. 4:199–203. 2010. View Article : Google Scholar
|
|
20
|
Christofori G: New signals from the
invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eriksson JE, Dechat T, Grin B, Helfand B,
Mendez M, Pallari HM and Goldman RD: Introducing intermediate
filaments: from discovery to disease. J Clin Invest. 119:1763–1771.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng GZ, Park S, Shu S, et al: Advances
of AKT pathway in human oncogenesis and as a target for anti-cancer
drug discovery. Curr Cancer Drug Targets. 8:2–6. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Onoue T, Uchida D, Begum NM, Tomizuka Y,
Yoshida H and Sato M: Epithelial-mesenchymal transition induced by
the stromal cell-derived factor-1/CXCR4 system in oral squamous
cell carcinoma cells. Int J Oncol. 29:1133–1138. 2006.PubMed/NCBI
|
|
25
|
Grille SJ, Bellacosa A, Upson J, et al:
The protein kinase Akt induces epithelial mesenchymal transition
and promotes enhanced motility and invasiveness of squamous cell
carcinoma lines. Cancer Res. 63:2172–2178. 2003.
|
|
26
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005.
|
|
27
|
Schramek H, Feifel E, Marschitz I,
Golochtchapova N, Gstraunthaler G and Montesano R: Loss of active
MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in
transdifferentiated MDCK cells. Am J Physiol Cell Physiol.
285:C652–C661. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park HJ, Gusarova G, Wang Z, et al:
Deregulation of FoxM1b leads to tumour metastasis. EMBO Mol Med.
3:21–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao M, Gao FH, Wang JY, Liu F, Yuan HH,
Zhang WY and Jiang B: JAK2/STAT3 signaling pathway activation
mediates tumor angiogenesis by upregulation of VEGF and bFGF in
non-small-cell lung cancer. Lung Cancer. 73:366–374. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bao B, Wang Z, Ali S, Kong D, et al:
Over-expression of FoxM1 leads to epithelial-mesenchymal transition
and cancer stem cell phenotype in pancreatic cancer cells. J Cell
Biochem. 112:2296–2306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu YQ, Guo RH, Liu LK, Gao W, Zhu CJ, Wei
J and Shu YQ: Correlation between expression of forkhead box M1
(FOXM1) and clinicopathological features and prognosis in patients
with non-small cell lung cancer (NSCLC). Zhonghua Zhong Liu Za Zhi.
33:426–430. 2011.(In Chinese).
|
|
33
|
Li LP, Lu CH, Chen ZP, et al: Subcellular
proteomics revealed the epithelial-mesenchymal transition phenotype
in lung cancer. Proteomics. 11:429–439. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang G, Dong W, Shen H, Mu X, Li Z, Lin X,
Liu Y and Du J: A comparison of Twist and E-cadherin protein
expression in primary non-small-cell lung carcinoma and
corresponding metastases. Eur J Cardiothorac Surg. 39:1028–1032.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pirozzi G, Tirino V, Camerlingo R, et al:
Epithelial to mesenchymal transition by TGFβ-1 induction increases
stemness characteristics in primary non small cell lung cancer cell
line. PLoS One. 6:e215482011.
|
|
36
|
Soltermann A, Tischler V, Arbogast S, et
al: Prognostic significance of epithelial-mesenchymal and
mesenchymal-epithelial transition protein expression in non-small
cell lung cancer. Clin Cancer Res. 14:7430–7437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao JQ, Sun FJ, Liu SS, et al: Expression
of connexin 43 and E-cadherin protein and mRNA in non-small cell
lung cancers in Chinese patients. Asian Pac J Cancer Prev.
14:639–643. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang X, Wang Z, Kang Y, Li X, Ma X and Ma
L: MCAM expression is associated with poor prognosis in non-small
cell lung cancer. Clin Transl Oncol. 16:178–183. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jin S, Zhu W, Shi Q, Zhang Z and Guo R:
Clinicopathological significance of lymphatic vessel density marked
by D2–40 and E-cadherin expression in non-small-cell lung cancer.
Med Oncol. 29:3157–3161. 2012.
|
|
40
|
Ucvet A, Kul C, Gursoy S, Erbaycu AE, Kaya
SO, Dinc ZA and Yucel N: Prognostic value of epithelial growth
factor receptor, vascular endothelial growth factor, E-cadherin,
and p120 catenin in resected non-small cell lung carcinoma. Arch
Bronconeumol. 47:397–402. 2011.(In Spanish).
|
|
41
|
Dauphin M, Barbe C, Lemaire S, et al:
Vimentin expression predicts the occurrence of metastases in non
small cell lung carcinomas. Lung Cancer. 81:117–122. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Irie HY, Pearline RV, Grueneberg D, et al:
Distinct roles of Akt1 and Akt2 in regulating cell migration and
epithelial-mesenchymal transition. J Cell Biol. 171:1023–1034.
2005. View Article : Google Scholar : PubMed/NCBI
|
